TRBV7-2
T cell receptor beta variable 7-2
Also known as: TCRBV6S5A1N1, TCRBV7S2, TRBV72, TVB72_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- A0A1B0GXF2
- Gene
- TRBV7-2
- Ensembl
- ENSG00000282939
- Chromosome
- 7
- Canonical length
- 115 aa
- Protein class
- Predicted intracellular proteins, T-cell receptor genes
- Quaternary structure
- Homodimer
OverviewNCBI Gene
Predicted to be involved in cell surface receptor signaling pathway. Predicted to be part of T cell receptor complex. Predicted to be active in plasma membrane. [provided by Alliance of Genome Resources, Apr 2025]
Canonical amino-acid sequenceUniProt
115 residues, UniProt reviewed canonical sequence.
>A0A1B0GXF2|TRBV7-2
1 MGTRLLFWVA FCLLGADHTG AGVSQSPSNK VTEKGKDVEL RCDPISGHTA LYWYRQSLGQ
61 GLEFLIYFQG NSAPDKSGLP SDRFSAERTG GSVSTLTIQR TQQEDSAVYL CASSLLocalizationUniProt · AlphaFold · HPA
Whether an antibody against TRBV7-2 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 0
- Highest tissue expression
- 80 nTPM
Expression across tissuesHPA
Tissue
- thymus: 80 nTPM
- lymph node: 45 nTPM
- tonsil: 40 nTPM
- epididymis: 33 nTPM
- appendix: 14 nTPM
- spleen: 5.4 nTPM
Single-cell type
- t-cells: 0.1 nCPM
- adipocytes: 0 nCPM
- adrenal cortex cells: 0 nCPM
- adrenal medulla cells: 0 nCPM
- alveolar cells type 1: 0 nCPM
- alveolar cells type 2: 0 nCPM
Immune cell
- T-reg: 572 nTPM
- memory CD4 T-cell: 399 nTPM
- naive CD4 T-cell: 303 nTPM
- memory CD8 T-cell: 179 nTPM
- naive CD8 T-cell: 111 nTPM
- total PBMC: 105 nTPM
Brain region
- hypothalamus: 2.2 nTPM
- basal ganglia: 0.3 nTPM
- cerebral cortex: 0.3 nTPM
- white matter: 0.2 nTPM
- amygdala: 0.1 nTPM
- medulla oblongata: 0.1 nTPM
OntologyGO
Biological processes
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads TRBV7-2 as an antibody target. Whether an autoantibody or antibody against TRBV7-2 could matter depends on whether native TRBV7-2 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
TRBV7-2 is annotated at the cell surface, where native TRBV7-2 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label TRBV7-2 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...